Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Sales | 6,475 | 6,014 | 6,696 | 6,317 | 6,149 |
| Gross Profit | 6,475 | 6,014 | 6,696 | 6,317 | 6,149 |
| Operating Expenses | 7,566 | 7,441 | 8,487 | 7,775 | 7,740 |
| Operating Income | -1,091 | -1,427 | -1,790 | -1,458 | -1,591 |
| Interest Expense | 99 | 98 | 113 | 111 | 3 |
| Other Income | -912 | 262 | 1,711 | 829 | -936 |
| Pre-tax Income | -2,102 | -1,263 | -192 | -740 | -2,530 |
| Income Tax | 10 | 7 | 22 | 16 | 150 |
| Net Income Continuous | -2,111 | -1,270 | -214 | -757 | -2,680 |
| Net Income | $-2,111 | $-1,270 | $-214 | $-757 | $-2,680 |
| EPS Basic Total Ops | -12.01 | -6.01 | 0.00 | -6.01 | -18.02 |
| EPS Basic Continuous Ops | -13.11 | -7.87 | -1.33 | -4.70 | -16.67 |
| EPS Diluted Total Ops | -12.01 | -6.01 | 0.00 | -6.01 | -18.02 |
| EPS Diluted Continuous Ops | -13.11 | -7.87 | -1.33 | -4.70 | -16.67 |
| EBITDA(a) | $-1,038 | $-1,358 | $-1,718 | $-1,382 | $-1,505 |